16 Geographic Atrophy Clinical Trials in Baltimore, MD (2026)

Q: How do I join a clinical trial in Baltimore?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Baltimore research site will contact you.

Recruiting Geographic Atrophy Studies in Baltimore

NCT06080698Recruiting

Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial

The Gram-negative bloodstream infection Oral Antibiotic Therapy trial (The GOAT Trial) is a multi-center, randomized clinical trial that hypothesizes that early transition to oral antibiotic therapy f...

Baltimore, MDNA1,030 participantsJohns Hopkins University

View Study Details

NCT02423070Recruiting

Genome Transplant Dynamics

Study Description: Heart and lung transplants can save lives, but long-term success is often limited by organ rejection that is hard to detect early. This study is testing a new, non-invasive blood t...

Baltimore, MD991 participantsNational Heart, Lung, and Blood Institute (NHLBI)

View Study Details

NCT06583239Recruiting

Hub-Based Engagement Navigator Service to Reduce CSC Disengagement

This project will develop a hub-based engagement navigator service for participants and families at high risk for disengagement. The investigators will use robust Participatory Research methods to ens...

Baltimore, MDNA555 participantsUniversity of Maryland, Baltimore

View Study Details

NCT04379596Recruiting

Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2-expressing Gastric Cancer (DESTINY-Gastric03)

DESTINY-Gastric03 will investigate the safety, tolerability, pharmacokinetics, immunogenicity, and preliminary antitumor activity of trastuzumab deruxtecan (T-DXd) alone or in combination with chemoth...

Baltimore, MDPHASE2450 participantsAstraZeneca

View Study Details

NCT06190730Recruiting

REmote Symptom COllection to improVE postopeRative Care

There are vulnerabilities in post-discharge care transition for patients after undergoing resection of malignant gastrointestinal tumors. This study aims to investigate the possibility of utilizing Vo...

Baltimore, MDNA281 participantsMedstar Health Research Institute

View Study Details

NCT05219617Recruiting

Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults

The primary objective is to evaluate the efficacy of carisbamate (YKP509) as adjunctive treatment in reducing the number of drop seizures (tonic, atonic, and tonic-clonic) compared with placebo in ped...

Baltimore, MDPHASE3252 participantsSK Life Science, Inc.

View Study Details

NCT05836103Recruiting

Testing the Impact of Smartphone-based Messaging to Support Young Adult Smoking Cessation

Clinical practice guidelines for smoking cessation emphasize cognitive behavioral therapy (CBT) to help patients develop coping strategies for urges. Mindfulness or Acceptance and Commitment Therapy (...

Baltimore, MDNA160 participantsJohns Hopkins Bloomberg School of Public Health

View Study Details

NCT06066996Recruiting

Evaluation of the Electronic Cigarette Withdrawal Syndrome

The goal of this project is to rigorously evaluate the nature of e-cigarette withdrawal in exclusive e-cigarette users during a monitored abstinence period and the role of nicotine in the expression o...

Baltimore, MDEARLY_PHASE1150 participantsJohns Hopkins University

View Study Details

NCT05627960Recruiting

First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies

This is a first in human phase 1 study of AG01 an anti-Progranulin/Glycoprotein88 (PGRN/GP88) antibody in patients with advanced solid tumors. AG01 is a recombinant monoclonal antibody expressed in a ...

Baltimore, MDPHASE177 participantsA&G Pharmaceutical Inc.

View Study Details

NCT06435000Recruiting

An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 Gene

This is an Observational Study to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 Gene This is a multicenter study which wil...

Baltimore, MD75 participantsSplice Bio

View Study Details

NCT06445322Recruiting

Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)

This is an observational prescreening study. Individuals who are eligible for prescreening will undergo testing procedures that may be used to determine eligibility in ACDN-01 clinical trials....

Baltimore, MD50 participantsAscidian Therapeutics, Inc

View Study Details

NCT04485559Recruiting

Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)

This phase I trial studies the side effects and best dose of trametinib and everolimus in treating pediatric and young adult patients with gliomas that have come back (recurrent). Trametinib acts by t...

Baltimore, MDPHASE150 participantsUniversity of California, San Francisco

View Study Details

NCT07182227Recruiting

PS-002 for the Treatment of IgA Nephropathy in Adults

The purpose of the study is to evaluate safety, tolerability, and preliminary effectiveness following administration of PS-002 in adults with primary Immunoglobulin A (IgA) nephropathy. This will be a...

Baltimore, MDPHASE132 participantsPurespring Therapeutics Limited

View Study Details

NCT05029999Recruiting

CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer

This research study is being done to find out if the immunotherapy drugs called CDX-301 and CDX-1140 in combination with the standard chemotherapy treatment pegylated liposomal doxorubicin (PLD, Doxil...

Baltimore, MDPHASE130 participantsUniversity of Texas Southwestern Medical Center

View Study Details

NCT03266640Recruiting

Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)

CMV cytotoxic T cells (CTLs) manufactured with the Miltenyi CliniMACS Prodigy Cytokine Capture System will be administered in children, adolescents and young adults (CAYA) with refractory cytomegalovi...

Baltimore, MDPHASE220 participantsNew York Medical College

View Study Details

NCT06467344Recruiting

Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)

This study is an open-label, single ascending dose clinical trial in participants who have ABCA4-related retinopathies. This is the first-in-human clinical trial in which ACDN-01 will be evaluated for...

Baltimore, MDPHASE115 participantsAscidian Therapeutics, Inc

View Study Details

About Geographic Atrophy Clinical Trials in Baltimore

Geographic atrophy is the advanced form of dry age-related macular degeneration, involving progressive loss of retinal cells. It leads to enlarging blind spots in central vision. Recently approved complement inhibitor therapies can slow progression.

There are currently 16 geographic atrophy clinical trials recruiting participants in Baltimore, MD. These studies are seeking a combined 4,218 participants. Research is being sponsored by Johns Hopkins University, National Heart, Lung, and Blood Institute (NHLBI), University of Maryland, Baltimore and 11 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Geographic Atrophy Clinical Trials in Baltimore — FAQ

Are there geographic atrophy clinical trials in Baltimore?

Yes, there are 16 geographic atrophy clinical trials currently recruiting in Baltimore, MD. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Baltimore?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Baltimore research site will contact you about next steps.

Are clinical trials in Baltimore free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Baltimore studies also compensate for your time and travel.

What geographic atrophy treatments are being tested?

The 16 active trials in Baltimore are testing new therapies including novel drugs, biologics, and treatment approaches for geographic atrophy.

Data updated July 18, 2026 from ClinicalTrials.gov